Infection Reducing Devices
Total Trials
7
As Lead Sponsor
5
As Collaborator
2
Total Enrollment
627
NCT01682486
BIP ETT Clinical Tolerability, Safety and Performance Study
Phase: N/A
Role: Lead Sponsor
Start: Apr 30, 2012
Completion: Jan 31, 2013
NCT02811380
BIP CVC Clinical Safety and Performance Study
Phase: Phase 4
Start: Sep 30, 2013
Completion: Jan 31, 2015
NCT02284438
Biofilm Formation on Different Endotracheal Tube Materials
Role: Collaborator
Start: Apr 30, 2014
Completion: Feb 29, 2020
NCT02808000
BIP Foley in Prevention of CAUTI at Rehab Station
Start: Apr 21, 2016
Completion: Mar 9, 2020
NCT04242706
VITAL - VAP Prevention by BIP (Bactiguard Infection Protection) ETT Evac in Belgian ICUs
Start: Oct 31, 2018
Completion: May 8, 2020
NCT03868241
Coated Devices to Decrease Infection in the Intensive Care Unit
Phase: Phase 1/2
Start: Apr 6, 2019
Completion: Feb 28, 2020
NCT03976557
BIP CVC in Access Center at Danderyd Hospital, Stockholm, Sweden
Start: Apr 11, 2019
Completion: Dec 18, 2019
Loading map...